BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Syndax Pharmaceuticals Inc. 



Waltham  Massachusetts    U.S.A.
Phone: 781-839-7301 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up





 Company News
Syndax Pharmaceuticals Inc. Release: Entinostat Improves Treatment Outcomes When Combined With Immune Checkpoint Blockade In Preclinical Tumor Models 7/30/2014 8:25:39 AM
Cancer Biotech Syndax Pharmaceuticals Inc. Sets Terms For $60 Million IPO 6/6/2014 6:58:28 AM
Syndax Pharmaceuticals Inc. Announces Presentation Of Entinostat Data In Two Posters At The 2014 American Society of Clinical Oncology (ASCO) Annual Meeting 5/27/2014 6:24:36 AM
Massachusett's Syndax Pharmaceuticals Inc. Plots $69 Million IPO For Cancer Drug's Stretch Run 3/28/2014 7:05:36 AM
Syndax Pharmaceuticals Inc. Announces National Cancer Institute And FDA Reach Agreement On A Special Protocol Assessment (SPA) For The Phase 3 Trial Of Entinostat In Patients With Advanced ER+ Breast Cancer 2/13/2014 11:29:41 AM
Leading Breast Cancer Expert, George W. Sledge, Jr., M.D., Joins Syndax Pharmaceuticals Inc. As An Independent Director 2/3/2014 6:39:00 AM
Syndax Pharmaceuticals Inc. Announces Appointment Of Richard P. Shea As Independent Director And Chair Of The Audit Committee 1/23/2014 6:47:29 AM
Syndax Pharmaceuticals Inc. Promotes John S. Pallies to Chief Financial Officer and Dr. Peter Ordentlich to Chief Technology Officer 11/1/2013 6:45:34 AM
Syndax Pharmaceuticals Inc. Names Steven M. Fruchtman, M.D., Chief Medical Officer 10/11/2013 6:14:02 AM
Syndax Pharmaceuticals Inc.'s Entinostat Receives Breakthrough Therapy Designation From FDA for Treatment of Advanced Breast Cancer 9/11/2013 9:29:34 AM
123456